Home
>
National Drug Code (NDC)
>
paclitaxel
paclitaxel - 0069-0079-01 - (paclitaxel)
Drug Information of paclitaxel
| Product NDC: | 0069-0079 |
| Proprietary Name: | paclitaxel |
| Non Proprietary Name: | paclitaxel |
| Active Ingredient(s): | 30 mg/5mL & nbsp; paclitaxel |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of paclitaxel
| Product NDC: | 0069-0079 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091540 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110930 |
Package Information of paclitaxel
| Package NDC: | 0069-0079-01 |
| Package Description: | 5 mL in 1 VIAL (0069-0079-01) |
NDC Information of paclitaxel
| NDC Code | 0069-0079-01 |
| Proprietary Name | paclitaxel |
| Package Description | 5 mL in 1 VIAL (0069-0079-01) |
| Product NDC | 0069-0079 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | paclitaxel |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110930 |
| Marketing Category Name | ANDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc. |
| Substance Name | PACLITAXEL |
| Strength Number | 30 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
